CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced its first order for the Helicos™ Genetic Analysis System. The system consists of the HeliScope™ Single Molecule Sequencer, the HeliScope™ Analysis Engine, and the HeliScope™ Sample Loader, all designed for production-level genetic analysis. Central to the platform is the company’s proprietary sequencing-by-synthesis approach called True Single Molecule Sequencing (tSMS)TM.
